Ambria has Successfully Closed a Financing Round

Ambria Dermatology AB is an innovative Swedish R&D company with a patented technology platform providing pharmaceutical product concepts and product development opportunities in dermatology, cosmeceuticals and hygiene products.

The new share issue of EUR 550000 will be utilized to continue the company R&D programme where in vitro studies and clinical studies in Phase II are included. The major part of financing has been invested by private investors and Innovationsbron Väst.

For further information please contact:

Monica Walter,

Tel: +46 733 861610

Email: monica.wallter@ambriadermatology.com

Or visit: www.ambriadermatology.com

Home > News & Events > News > Ambria has Successfully Closed a Financing Round
Last updated: 2006-12-22

The official Medicon Valley site is brought to you by the organisations Region Skåne and Copenhagen Capacity - in association with Medicon Valley Alliance

Contact:
Copenhagen Capacity,	tel: +45 33 22 02 22
Region Skåne,	tel: +46 (0)40 623 97 48

AMBRIA DERMATOLOGY AB

AMBRIA DERMATOLOGY is a research and development company focusing on new solutions in dermatology science. The patented technology platform includes pentane-1,5-diol delivery platform for improving the dermal delivery of topically applied pharmaceuticals, cosmeceuticals and products for technic...